Last reviewed · How we verify
NCT03661931
Dietary Quality Photo Navigation (DQPN) Preliminary Validation Study
NA trial testing DQPN Validation in Lifestyle-related Condition in 150 participants. Status unknown.
1 March 2019
Quick facts
| Lead sponsor | Boston Heart Diagnostics |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 150 |
| Start date | 11 September 2018 |
| Primary completion | 1 March 2019 |
| Estimated completion | 1 June 2019 |
Drugs / interventions tested
- DQPN Validation
Conditions studied
- Lifestyle-related Condition — all drugs for Lifestyle-related Condition →
- Nutrient; Excess — all drugs for Nutrient; Excess →
Sponsor
Boston Heart Diagnostics
Who can join
18 and older, any sex, with Lifestyle-related Condition or Nutrient; Excess. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this research project is to conduct a preliminary validation study of the Diet Quality Photo Navigation (DQPN) method of dietary intake assessment. In 150 adults, dietary intake as estimated by the DQPN will be compared to dietary intake as estimated by a food frequency questionnaire (FFQ) and with blood levels of fatty acids, folic acid, and beta-carotene as biomarkers of dietary intake.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03661931
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Lifestyle-related Condition
Currently open trials in the same condition.
- NCT06688461 — High Intensity Interval Training and Insulin Sensitivity in Type 2 Diabetes · NA · recruiting
Other Boston Heart Diagnostics trials
Trials by the same sponsor.
- NCT03322046 — Heartmatters Challenge - First Responders · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03661931 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Boston Heart Diagnostics
- Last refreshed: 7 September 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03661931.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing